Indivior Pharmaceuticals, Inc. (INDV) Operating cash flow 2022–2025
Indivior Pharmaceuticals, Inc. (INDV) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$27.0MFY2025 · since FY2022: -$4.0M → -$27.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$27.0M | -175.0% |
| FY2024 | $36.0M | +112.0% |
| FY2023 | -$300.0M | -7400.0% |
| FY2022 | -$4.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More INDV financial trends
INDV RevenueINDV Net incomeINDV Net marginINDV Gross profitINDV Gross marginINDV Operating incomeINDV Operating marginINDV Free cash flowINDV Capital expendituresINDV Return on equityINDV Stock buybacksINDV Dividends paidINDV Total assetsINDV Total liabilitiesINDV Shareholders’ equityINDV overview →